4//SEC Filing
NEA 13 GP, Ltd 4
Accession 0001209191-24-002498
CIK 0001400118other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:56 PM ET
Size
11.8 KB
Accession
0001209191-24-002498
Insider Transaction Report
Form 4
NEA Partners 13, Limited Partnership
10% Owner
Transactions
- Other
Series A Common Stock
2024-01-29−850,000→ 3,000,275 total(indirect: See Note 2) - Other
Series A Common Stock
2024-01-29+260,950→ 260,950 total - Other
Series A Common Stock
2024-01-29−260,950→ 0 total
NEA 13 GP, Ltd
10% Owner
Transactions
- Other
Series A Common Stock
2024-01-29−850,000→ 3,000,275 total(indirect: See Note 2) - Other
Series A Common Stock
2024-01-29+260,950→ 260,950 total - Other
Series A Common Stock
2024-01-29−260,950→ 0 total
Footnotes (5)
- [F1]New Enterprise Associates 13, L.P. ("NEA 13") made a pro rata distribution of 850,000 shares of Series A Common Stock of the Issuer to its general partner and limited partners for no consideration on January 29, 2024.
- [F2]The securities are directly held by NEA 13 and are indirectly held by NEA Partners 13, L.P. ("NEA Partners 13"), the sole general partner of NEA 13, NEA 13 GP, LTD ("NEA 13 LTD"), the sole general partner of NEA Partners 13, and the individual directors of NEA 13 LTD (NEA Partners 13, NEA 13 LTD and the individual directors (collectively, the "Directors"), together, the "Indirect Reporting Persons"). The Directors of NEA 13 LTD are Forest Baskett, Patrick J. Kerins and Scott D. Sandell. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 13 in which the Indirect Reporting Persons have no pecuniary interest.
- [F3]NEA Partners 13 received 260,950 shares of Series A Common Stock of the Issuer in the distribution made by NEA 13 on January 29, 2024.
- [F4]The securities are directly held by NEA Partners 13 and indirectly held by NEA 13 LTD, the sole general partner of NEA Partners 13, and the Directors (NEA 13 LTD and the Directors together, the "NEA Partners 13 Indirect Reporting Persons"). The NEA Partners 13 Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA Partners 13 in which the NEA Partners 13 Indirect Reporting Persons have no pecuniary interest.
- [F5]NEA Partners 13 made a pro rata distribution for no consideration of an aggregate of 260,950 shares of Series A Common Stock of the Issuer to its limited partners on January 29, 2024.
Documents
Issuer
Sagimet Biosciences Inc.
CIK 0001400118
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001460751
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:56 PM ET
- Size
- 11.8 KB